Monoclonal antibodies
This is a kind of targeted therapy that uses antibodies made in a lab. The antibodies are like the ones your immune system makes naturally. They attach to proteins on CLL cells and kill the cells or stop them from growing.
Monoclonal antibodies are often used alone, with other targeted therapy, or with chemo as part of the first treatment for CLL. They may also be used if other treatments don't work, or if the leukemia comes back after treatment. They might be the only treatment used for someone who's too sick to get chemo.
Monoclonal antibodies used to treat CLL include:
- Rituximab.
- Ofatumumab.
- Obinutuzumab.
- Alemtuzumab.
BTK (Bruton tyrosine kinase) inhibitors
These medicines block BTK inside leukemia cells. BTK normally helps cancer cells grow and survive.
BTK inhibitors used to treat CLL include:
- Ibrutinib.
- Acalabrutinib.
- Zanubrutinib.
- Pirtobrutinib.
Venetoclax
This medicine is a BCL-2 inhibitor. It targets the BCL-2 protein in CLL cells that helps them live longer than they should. It's taken as a pill. It can be used alone or with a monoclonal antibody.
PI3K inhibitors
PI3K is a protein that helps cells grow and survive. The medicines block this protein, which kills CLL cells and keeps them from growing. They may be used if other treatments stop working. They're taken every day as a pill.
- Idelalisib.
- Duvelisib.
- Idelalisib (specifically blocks PI3K-delta).